切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2026, Vol. 20 ›› Issue (01) : 87 -96. doi: 10.3877/cma.j.issn.1674-134X.2026.01.011

综述

卫虚-血瘀-髓痿理论治疗激素性股骨头坏死的价值
何琪1,2,3,4, 周月惠4,5, 薛宇轩4,5, 吉宇通4,5, 王海彬1,2,4, 周驰1,2,3,6,()   
  1. 1510405 广州中医药大学第一附属医院人工关节与髋关节科
    2510405 广州,广东省中医临床研究院
    3510095 广州中医药大学博士后流动站
    4510388 广州中医药大学岭南医学研究中心
    5510405 广州中医药大学第一临床医学院
    6525022 茂名,广州中医药大学茂名医院(茂名市中医院)
  • 收稿日期:2026-01-29 出版日期:2026-02-01
  • 通信作者: 周驰
  • 基金资助:
    国家自然科学基金(82474539); 广东省医学科学技术研究基金项目(A2024056); 茂名市中医药创新发展计划项目(2023SZY008); 茂名市科技创新发展计划项目(2024kjcxLX006); 广东省中医药局中医药科研项目(202405131119265470)

Therapeutic value of Wei deficiency-blood stasis-marrow atrophy theory in steroid-induced femoral head osteonecrosis

Qi He1,2,3,4, Yuehui Zhou4,5, Yuxuan Xue4,5, Yutong Ji4,5, Haibin Wang1,2,4, Chi Zhou1,2,3,6,()   

  1. 1Department of Arthroplasty and Hip Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China
    2Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou 510405, China
    3Postdoctoral Research Station, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
    4Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
    5The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
    6Maoming Hospital of Guangzhou University of Chinese Medicine, Maoming 525022, China
  • Received:2026-01-29 Published:2026-02-01
  • Corresponding author: Chi Zhou
引用本文:

何琪, 周月惠, 薛宇轩, 吉宇通, 王海彬, 周驰. 卫虚-血瘀-髓痿理论治疗激素性股骨头坏死的价值[J/OL]. 中华关节外科杂志(电子版), 2026, 20(01): 87-96.

Qi He, Yuehui Zhou, Yuxuan Xue, Yutong Ji, Haibin Wang, Chi Zhou. Therapeutic value of Wei deficiency-blood stasis-marrow atrophy theory in steroid-induced femoral head osteonecrosis[J/OL]. Chinese Journal of Joint Surgery(Electronic Edition), 2026, 20(01): 87-96.

激素性股骨头坏死(SONFH)是一种以骨髓微环境长期失衡为核心特征的非创伤性骨坏死性疾病,其发生发展过程难以仅用血供障碍或骨组织坏死加以解释。Adipoq+骨髓间充质干细胞(MALP)作为骨髓特异性的间充质细胞亚群,在骨髓稳态调控、血管重建及骨重塑过程中发挥重要作用,但其在SONFH中的潜在功能及病理意义尚缺乏系统阐释。本文将"卫虚-血瘀-髓痿"理论融入近年关于MALP的研究进展,从骨髓微环境整体失衡的视角,对MALP在SONFH发生发展中的可能作用机制进行阐述。MALP在激素性股骨头坏死中并非单纯的脂肪生成相关细胞,而是贯穿疾病不同阶段、深度参与骨髓微环境重构的重要调控节点:在"卫虚"阶段,长期或大剂量使用糖皮质激素可诱导MALP异常扩增,骨髓稳态调控能力下降;在"血瘀"阶段,MALP通过分泌血管调控因子参与血管稳态调节,其功能失衡可影响微循环重建,同时以核因子κB受体活化因子配体(RANKL)依赖性方式显著促进破骨细胞生成,推动血管功能障碍与骨吸收增强在骨髓微环境中的耦合放大;在"髓痿"阶段,MALP进一步向脂肪细胞和肌成纤维细胞转变,其稳态调控与修复支持功能持续衰减,骨髓修复潜能逐步耗竭,最终导致血供难以恢复和骨结构不可逆损伤。"卫虚—血瘀—髓痿"理论为从整体和动态角度理解MALP的阶段性功能转变提供了有力框架。围绕MALP可塑性及其微环境调控功能开展进一步研究,或可为SONFH的防治及中医药干预策略的优化提供新的理论依据和研究方向。

Steroid-induced osteonecrosis of the femoral head (SONFH) is a non-traumatic osteonecrotic disorder characterized by persistent disruption of the bone marrow microenvironment, a process that cannot be fully explained by vascular insufficiency or bone tissue necrosis alone. Emerging evidence has identified marrow adipogenic lineage precursors (MALPs) as a bone marrow-specific mesenchymal cell subpopulation that plays a critical role in regulating marrow homeostasis, vascular remodeling, and bone turnover. However, the functional significance and pathological involvement of MALPs in SONFH remain insufficiently defined.This review integrated recent advances in MALP biology with the traditional Chinese medicine (TCM) theory of Wei deficiency-blood stasis-marrow atrophy, and systematically analyze the potential stage-dependent roles of MALPs in the initiation and progression of SONFH from the perspective of global bone marrow microenvironmental imbalance. Available evidence suggests that during Wei deficiency stage, long-term or high-dose glucocorticoid use may induce abnormal expansion of MALPs, accompanied by impaired marrow homeostatic regulation. During the blood stasis stage, MALPs participate in vascular regulation through the secretion of angiogenic factors, while their functional dysregulation disrupts microcirculatory reconstruction and markedly promotes osteoclastogenesis in a receptor activator of nuclear ractor kappa B ligand (RANKL)-dependent manner, thereby amplifying the coupling between vascular dysfunction and excessive bone resorption. In the marrow atrophy stage, MALPs undergo further fate shifts toward adipocytes and myofibroblasts, resulting in sustained loss of regulatory and reparative capacity, progressive exhaustion of marrow regenerative potential, and ultimately irreversible vascular compromise and structural bone damage.Collectively, MALPs should not be regarded merely as adipogenesis-related cells in SONFH, but rather as central regulatory nodes that dynamically participate in bone marrow microenvironmental remodeling across disease stages. Wei deficiency-blood stasis-marrow atrophy theory provides a coherent conceptual framework for understanding the stage-specific functional transitions of MALPs in SONFH. Further investigation into MALP plasticity and microenvironmental regulatory functions may offer novel mechanistic insights and support the optimization of TCM -based therapeutic strategies for SONFH.

图1 MALP(骨髓脂肪生成谱系前体)在骨髓微环境稳态调控中的功能定位示意图注:Mesenchymal progenitors-间充质祖细胞;Osteoblast-成骨细胞;Lipid-laden adipocytes-富含脂质的脂肪细胞;Bone lining cell-骨膜细胞;Osteocyte:骨细胞;Osteoclast-破骨细胞;Vessel maintenance-血管维持;Bone formation-骨形成;Bone resorption-骨吸收;RANKL-核因子κB受体活化因子配体;RANK-核因子κB受体活化因子
Figure 1 Diagram of function positioning of MALP (marrow adipogenic lineage precursor) in homeostasis regulation of bone marrow microenvironment
图2 Adipoq Cre-td小鼠SONFH(激素性股骨头坏死)模型中股骨头组织荧光成像(比例尺:200μm)注:左侧为对照组,右侧为糖皮质激素诱导的股骨头坏死模型组;红色荧光为TdTomato标记细胞,与对照组相比,激素处理后股骨头结构明显紊乱,TdTomato标记细胞分布范围显著改变
Figure 2 Fluorescence imaging of femoral head tissue of Adipoq Cre-td mice model of SONFH(scale: 200μm)
图3 AdipoqCre-td小鼠激素诱导后股骨头组织中3种细胞的免疫荧光共定位(比例尺:20μm)注:左图为细胞核(蓝色)/脂滴包被蛋白(perilipin)(绿色,示脂肪细胞)/ Adipoq+细胞(红色)三重免疫荧光染色,右图为细胞核(蓝色)/αSMA(α-平滑肌肌动蛋白)(绿色,示肌成纤维细胞)/ Adipoq+细胞(红色)三重免疫荧光染色;箭头示Adipoq+细胞与脂肪细胞或肌成纤维细胞的空间共定位情况
Figure 3 Spatial colocalization by immuno fluorescence of three types of cell in glucocoticoid induced femoral head tissue of Adipoq Cre-td mice (scale: 200μm)
图4 基于卫虚-血瘀-髓痿理论MALP(骨髓脂肪生成谱系前体)在骨髓微环境稳态与SONFH(激素性股骨头坏死)病理状态下的失衡作用机制
Figure 4 Imbalance mechanism of bone marrow microenviroment homeostasis of MALP and pathological status of SONFH base on Wei deficiency-blood stasis-marrow atrophy theory
[1]
冉兴宇, 张晓峰. 基于"治未病"理论探讨中西医防治激素性股骨头坏死[J]. 临床个性化医学, 2024, 3(4): 1428-1434.
[2]
Huang C, Wen Z, Niu J, et al. Steroid-induced osteonecrosis of the femoral head: novel insight into the roles of bone endothelial cells in pathogenesis and treatment[J/OL]. Front Cell Dev Biol, 2021, 9: 777697. DOI:10.3389/fcell.2021.777697.
[3]
葛建勋, 孙水. 糖皮质激素诱导股骨头坏死发病机制的研究进展[J]. 临床医学进展, 2024(4): 1218-1223.
[4]
孙懿, 赵海燕, 成杰, 等. 激素性股骨头坏死发生机制的研究进展[J]. 中国矫形外科杂志, 2023, 31(1): 58-62.
[5]
魏秋实, 何伟, 张庆文, 等. 围塌陷期股骨头坏死不同影像学表现研究[J]. 中国修复重建外科杂志, 2021, 35(9): 1105-1110.
[6]
Kindt M, Jönsson ML, Torfing T, et al. Assessing osteonecrosis of the femoral head after internal fixation of femoral neck fractures in young patients with fixation implants in situ: the value of MARS MRI in relation to conventional radiography and patient-reported outcomes[J]. Acta Orthop, 2023, 94: 135-140.
[7]
何伟. 科学看待中医药治疗非创伤性股骨头坏死[J/OL]. 中华关节外科杂志(电子版), 2013, 7(3): 1-2.
[8]
Mourad C, Omoumi P, Vande Berg B. The many faces of marrow necrosis[J]. Semin Musculoskelet Radiol, 2023, 27(1): 103-113.
[9]
Zhang S, Wang H, Meng Q, et al. Recent advances in osteonecrosis of the femoral head: a focus on mesenchymal stem cells and adipocytes[J/OL]. J Transl Med, 2025, 23(1): 592. DOI:10.1186/s12967-025-06564-6.
[10]
Duan P, Wang H, Yi X, et al. C/EBPα regulates the fate of bone marrow mesenchymal stem cells and steroid-induced avascular necrosis of the femoral head by targeting the PPARγ signalling pathway[J/OL]. Stem Cell Res Ther, 2022, 13(1): 342. DOI:10.1186/s13287-022-03027-3.
[11]
Zhong L, Yao L, Seale P, et al. Marrow adipogenic lineage precursor: a new cellular component of marrow adipose tissue[J/OL]. Best Pract Res Clin Endocrinol Metab, 2021, 35(4): 101518. DOI:10.1016/j.beem.2021.101518.
[12]
中国中医药研究促进会中医骨伤临床循证医学分会, 何伟, 王智勇. 非创伤性股骨头坏死中西医结合诊疗专家共识[J]. 中医正骨, 2024, 36(9): 1-11.
[13]
袁普卫, 康武林, 刘德玉, 等. 中医对股骨头缺血性坏死病因病机的认识[J]. 现代中医药, 2013, 33(6): 90-93.
[14]
魏秋实, 何伟, 张庆文, 等. 股骨头坏死中医证型分布规律的文献研究和系统评价[J/OL]. 中华关节外科杂志(电子版), 2013, 7(3): 63-66.
[15]
Li L, Zhao S, Leng Z, et al. Pathological mechanisms and related markers of steroid-induced osteonecrosis of the femoral head[J/OL]. Ann Med, 2024, 56(1): 2416070. DOI:10.1080/07853890.2024.2416070.
[16]
Yang X, Yang P, Liao J, et al. New insights into the mechanism of microvascular rarefaction via endothelial-mesenchymal transition in steroid-induced osteonecrosis of femoral head[J/OL]. Sci Rep, 2025, 16(1): 986. DOI:10.1038/s41598-025-30454-y.
[17]
Sheng H, Sheng CJ, Cheng XY, et al. Pathomorphological changes of bone marrow adipocytes in process of steroid-associated osteonecrosis[J]. Int J Clin Exp Pathol, 2013, 6(6): 1046-1050.
[18]
Zhao FC, Hu HX, Zheng X, et al. Clinical analysis of 23 cases of steroid-associated osteonecrosis of the femoral head with normal initial magnetic resonance imaging presentation[J/OL]. Medicine, 2017, 96(49): e8834. DOI:10.1097/MD.0000000000008834.
[19]
Chen KY, Li XH, Chen D, et al. PPARγ inhibitors enhance the efficacy of statin therapy for steroid-induced osteonecrosis of the femoral head by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions[J/OL]. PLoS One, 2025, 20 (6): e0325190. DOI:10.1371/journal.pone.0325190.
[20]
Funk JA, Lejeune JT, Wittum TE, et al. The effect of subtherapeutic chlortetracycline on antimicrobial resistance in the fecal flora of swine[J]. Microb Drug Resist, 2006, 12(3): 210-218.
[21]
Visco C, Medeiros LJ, Mesina OM, et al. Non-Hodgkin’s lymphoma affecting the testis: is it curable with doxorubicin-based therapy?[J]. Clin Lymphoma, 2001, 2(1): 40-46.
[22]
Houdek MT, Wyles CC, Packard BD, et al. Decreased osteogenic activity of mesenchymal stem cells in patients with corticosteroid-induced osteonecrosis of the femoral head[J]. J Arthroplasty, 2016, 31(4): 893-898.
[23]
Han L, Wang B, Wang R, et al. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor[J/OL]. Stem Cell Res Ther, 2019, 10(1): 377. DOI:10.1186/s13287-019-1498-0.
[24]
Li J, Li Y, Wang Y, et al. Preventive effects of siRNA targeting PPARγ gene on steroid-induced osteonecrosis in rabbits[J]. Connect Tissue Res, 2014, 55(5-6): 322-330.
[25]
Yu H, Liu P, Zuo W, et al. Decreased angiogenic and increased apoptotic activities of bone microvascular endothelial cells in patients with glucocorticoid-induced osteonecrosis of the femoral head[J/OL]. BMC Musculoskelet Disord, 2020, 21(1): 277. DOI:10.1186/s12891-020-03225-1.
[26]
Choi H-R, Steinberg ME, Y Cheng E. Osteonecrosis of the femoral head: diagnosis and classification systems[J]. Curr Rev Musculoskelet Med, 2015, 8(3): 210-220.
[27]
Zhao D, Zhang F, Wang B, et al. Guidelines for clinical diagnosis and treatment of osteonecrosis of the femoral head in adults (2019 version)[J]. J Orthop Translat, 2020, 21: 100-110.
[28]
Rohilla B, Dharmalingam L, Kamalakannan G, et al. A descriptive study on the role of magnetic resonance imaging in staging avascular necrosis of the hip joint: current trends and insights[J/OL]. Cureus, 2025, 17(6): e86867. DOI:10.7759/cureus.86867.
[29]
Pierce TP, Jauregui JJ, Cherian JJ, et al. Imagingevaluation of patientswithosteonecrosisofthefemoral head[J]. Curr Rev Musculoskelet Med, 2015, 8(3): 221-227.
[30]
Zhang Y, Nicholatos J, Dreier JR, et al. Coordinated regulation of protein synthesis and degradation by mTORC1[J]. Nature, 2014, 513(7518): 440-443.
[31]
陈刚. 试论中医理论中的免疫学思想[J]. 吉林中医药, 2006, 26(4): 1-3.
[32]
Coutinho AE, Chapman KE. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights[J]. Mol Cell Endocrinol, 2011, 335(1): 2-13.
[33]
陈可冀. 关于瘀血证研究的国内外进展[J]. 临床荟萃, 1987, 2(1): 16-18.
[34]
王德羽, 焦裕隆, 龚麒麟, 等. 基于"瘀阻骨络"理论探讨铁蓄积与骨质疏松症关系[J]. 辽宁中医药大学学报, 2025, 27(6): 140-145.
[35]
Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone[J]. Nature, 2014, 507(7492): 323-328.
[36]
Peng Y, Wu S, Li Y, et al. Type H blood vessels in bone modeling and remodeling[J]. Theranostics, 2020, 10(1): 426-436.
[37]
Stegen S, Carmeliet G. The skeletal vascular system–Breathing life into bone tissue[J]. Bone, 2018, 115: 50-58.
[38]
Balakrishna Pillai A, Mariappan V, JeanPierre AR, et al. Restoration of vascular endothelial integrity by mesenchymal stromal/stem cells in debilitating virus diseases[J]. Hum Cell, 2022, 35(6): 1633-1639.
[39]
马金辉, 任岩松, 王佰亮, 等. H亚型血管在股骨头坏死中的作用机制研究进展[J]. 中国修复重建外科杂志, 2021,35(11): 1486-1491.
[40]
Tao J, Cao X, Yu B, et al. Vascular stem/progenitor cells in vessel injury and repair[J/OL]. Front Cardiovasc Med, 2022, 9: 845070. DOI:10.3389/fcvm.2022.845070.
[41]
Zhong L, Yao L, Tower RJ, et al. Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment[J/OL]. eLife, 2020, 9: e54695. DOI:10.7554/eLife.54695.
[42]
ZhongL, YaoL, HoldreithN, et al. Transientexpansionandmyofibroblastconversionofadipogeniclineageprecursorsmediatebonemarrowrepairafter radiation[J/OL]. JCI Insight, 2022, 7(7): e150323. DOI:10.1172/jci.insight.150323.
[43]
Leaungwutiwong P, Bamrungsak B, Jittmittraphap A, et al. Molecular genotyping of human papillomavirus l1 gene in low-risk and high-risk populations in Bangkok[J]. Sex Transm Dis, 2015, 42(4): 208-217.
[44]
Zhang P, Xu H, Wang P, et al. Yougui pills exert osteoprotective effects on rabbit steroid-related osteonecrosis of the femoral head by activating β-catenin[J/OL]. Biomed Pharmacother, 2019, 120: 109520. DOI:10.1016/j.biopha.2019.109520.
[45]
Suda T, Kobayashi K, Jimi E, et al. The molecular basis of osteoclast differentiation and activation[J]. Novartis Found Symp, 2001, 232: 235-247;discussion247-50.
[46]
Xiong J, Piemontese M, Onal M, et al. Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone[J/OL]. PLoS One, 2015, 10(9): e0138189. DOI:10.1371/journal.pone.0138189.
[47]
Yu W, Zhong L, Yao L, et al. Bone marrow adipogenic lineage precursors promote osteoclastogenesis in bone remodeling and pathologic bone loss[J/OL]. J Clin Invest, 2021, 131(2): e140214. DOI:10.1172/JCI140214.
[48]
张兆坤, 赵俊杰, 王玺玉, 等. 股骨头坏死中骨微血管内皮细胞对氧化应激性损伤的修复机制[J]. 中华骨与关节外科杂志, 2024, 17(10): 950-956.
[49]
张淼, 冯圣一, 程国全. 激素性股骨头坏死发生发展及中药干预过程中骨髓间充质干细胞表观遗传修饰的研究进展[J]. 中医正骨, 2025, 37(6): 40-45.
[50]
Wang H, Yao L, Zhong L, et al. Marrow adipogenic lineage precursors (MALPs) facilitate bone marrow recovery after chemotherapy[J/OL]. Bone, 2025, 195: 117446. DOI:10.1016/j.bone.2025.117446.
[51]
Yang B, Su J, Wu J, et al. Macrophage-derived amphiregulin induces myofibroblast transition in adipogenic lineage precursors near Staphylococcus aureus abscess in bone marrow[J/OL]. Nat Commun, 2025, 16(1): 8409. DOI:10.1038/s41467-025-63551-7.
[52]
席洪钟, 陈浩, 何帅, 等. 右归饮通过调节PPARγ通路减轻骨髓间充质干细胞成脂分化治疗糖皮质激素诱导的骨坏死[J]. 中国中药杂志, 2025, 50(12): 3356-3367.
[53]
梁学振, 杨曦, 李嘉程, 等. 补肾活血胶囊介导Hedgehog信号通路调控大鼠骨髓间充质干细胞成骨成脂分化[J]. 中国组织工程研究, 2022, 26(7): 1020-1026.
[1] 王宏达, 单兴宇, 张浩强, 田志敏, 李焕玺, 何淳诺, 庄凯鹏, 周胜虎, 甄平. 人工骨修复材料在股骨头坏死修复中的应用[J/OL]. 中华关节外科杂志(电子版), 2026, 20(01): 77-86.
[2] 彭兵. 联合血管切除重建的腹腔镜胰十二指肠切除术实践与探索[J/OL]. 中华普通外科学文献(电子版), 2026, 20(1): 23-23.
[3] 彭兵. 联合血管切除重建的腹腔镜胰十二指肠切除术实践与探索[J/OL]. 中华普通外科学文献(电子版), 2026, 20(01): 23-23.
[4] 陈玉, 韩戟, 杨力. CT血管成像对肠系膜下动脉分型评估及腹腔镜直肠癌手术的指导价值[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(02): 162-165.
[5] 李志军, 李宏伟, 吕瑞昌, 黄勇, 尚培中, 李晓武. 腹腔镜脾部分切除治疗脾脏硬化性血管瘤样结节性转化一例并文献复习[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(01): 75-77.
[6] 林新杰, 郑轶群, 苏镓洛, 孔杰, 邓奕洲, 雷昊鑫. 精索静脉曲张患者精索内静脉血管平滑肌细胞雄激素受体表达和血清睾酮水平的研究[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 65-70.
[7] 霍颖钊, 刘创明, 梁任. 肾上腺术后肾上腺危象诊疗分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(01): 84-88.
[8] 梅春霞, 冯霞, 邬海桥, 刘攀, 李昆霖, 徐智, 刘禹. 肺损伤预测评分联合血管生成素-2对肺部感染并发急性呼吸窘迫综合征的预测意义[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 9-14.
[9] 黄立政, 王玉倩, 姜金兰, 韩方雷. 间充质干细胞改善术后认知功能障碍的作用机制与研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(01): 45-51.
[10] 戴宗伯, 张城硕, 郭庭维, 何知远, 赵昊宇, 张宇慈, 张佳林. 基于MRI影像组学机器学习构建肝细胞癌微血管侵犯预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 36-44.
[11] 何泰霖, 王峻峰, 田林云, 王罡, 杨超, 王海峰. 基于CT影像组学构建肝细胞癌微血管侵犯预测模型[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(01): 45-52.
[12] 陆雅斐, 皇甫少华, 杨旭, 朱勇, 周春根, 郑正, 马传学, 王大伟, 陈澳, 林宏城, 廖联明, 江滨. 脐带间充质干细胞治疗克罗恩病肛瘘的长期疗效和安全性临床观察[J/OL]. 中华结直肠疾病电子杂志, 2026, 15(01): 72-84.
[13] 王玥, 黄雅慧, 乔会侠, 张鹏. 益气生血方联合双歧杆菌四联活菌片对慢性胃溃疡患者肠道菌群、胃肠激素及血清核因子κB、白细胞介素-6的影响[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(01): 36-40.
[14] 唐月华, 曹友红, 袁晨, 陈越亚, 马亦旻, 刘燕燕. 缺血性肠病患者D-二聚体、肠道脂肪酸结合蛋白变化及CT血管成像特征的临床研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(01): 41-46.
[15] 王甜, 张勇, 李苗红, 刘佳玥. MRI动态增强扫描联合CT能谱成像对肝细胞癌微血管侵犯的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(01): 6-12.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?